| 22.04.2024 10:11 | EVG | Holding(s) in Company | RNS |
| 11.04.2024 15:04 | EVG | Holding(s) in Company | RNS |
| 09.04.2024 07:00 | EVG | Holding(s) in Company | RNS |
| 08.04.2024 16:03 | EVG | Holding(s) in Company | RNS |
| 05.04.2024 15:39 | EVG | Director/PDMR Shareholding | RNS |
| 05.04.2024 14:40 | EVG | Holding(s) in Company | RNS |
| 04.04.2024 17:24 | SBSI, SAR, CODE | TRADING UPDATES: Northcoders launches bootcamp; Schroder invests | Alliance |
| 04.04.2024 13:59 | EVG | Result of General Meeting | RNS |
| 04.04.2024 07:00 | EVG | Result of Retail Offer | RNS |
| 19.03.2024 19:47 | API, CREI, EVG | EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat | Alliance |
| 19.03.2024 17:03 | EVG | Retail Offer | RNS |
| 19.03.2024 17:00 | EVG | Acquisition, Fundraising and Change of Name | RNS |
| 27.02.2024 15:59 | EVG | Evgen Pharma finds evidence of SFX-01 activity in colon cancer models | Alliance |
| 27.02.2024 07:00 | EVG | SFX-01 positive update in bowel cancer models | Reach |
| 19.02.2024 11:45 | EVG | Evgen Pharma shares up on studies into SFX-01 product progressing well | Alliance |
| 19.02.2024 11:22 | EVG | Positive update on SFX-01 in vitro GBM studies | Reach |
| 09.02.2024 18:53 | SUH, APAX, DCI | TRADING UPDATES: Apax opts against lifting offer; DCI enters loan deal | Alliance |
| 16.01.2024 18:59 | EVG | IN BRIEF: Evgen partner raises USD17.4 million to support pipeline | Alliance |
| 16.01.2024 15:07 | EVG | Series B Fund Raise by partner, Stalicla SA | Reach |
| 29.12.2023 11:29 | EVG | Holding(s) in Company | RNS |
| 22.12.2023 18:06 | EVG | IN BRIEF: Evgen appoints Toni Hanninen as permanent CFO | Alliance |
| 22.12.2023 07:00 | EVG | Directorate Changes | RNS |
| 13.11.2023 07:00 | EVG | Upcoming conferences | Reach |
| 31.10.2023 14:38 | STG, CGEO, EVG | TRADING UPDATES: Acuity RM wins contract; Georgia Capital ups earnings | Alliance |
| 31.10.2023 07:00 | EVG | Half-year Report | RNS |
| 26.10.2023 07:00 | EVG | Erasmus Medical Center begins glioblastoma studies | Reach |
| 19.10.2023 19:39 | EVG | IN BRIEF: Evgen showcases importance of new enteric-coated formulation | Alliance |
| 19.10.2023 14:26 | EVG | Authored Article Publication | Reach |
| 05.09.2023 14:22 | FARN, EVG | Evgen Pharma hires interim CFO from Faron, chair to retire this month | Alliance |
| 05.09.2023 07:00 | EVG | Directorate Changes | RNS |
| 15.08.2023 10:01 | EVG | Evgen Pharma says trial shows new SFX-01 drug formulation is safe | Alliance |
| 15.08.2023 07:00 | EVG | Final Report from Phase 1b PK/PD study | RNS |
| 03.08.2023 12:38 | EVG | Rule 17 Disclosure | RNS |
| 02.08.2023 10:28 | EVG | IN BRIEF: Evgen Pharma shares drop on ending of license agreement | Alliance |
| 02.08.2023 10:09 | EVG, DEMG | AIM WINNERS & LOSERS: Deltex plummets on return to AIM; Blancco rises | Alliance |
| 02.08.2023 07:00 | EVG | Return of rights to Sulforadex from Juvenescence | RNS |
| 21.07.2023 12:02 | EVG | Result of AGM | RNS |
| 13.07.2023 15:58 | WKOF, TRY, SSE | UK shareholder meetings calendar - next 7 days | Alliance |
| 27.06.2023 10:17 | PYC, ELCO, EVG | AIM WINNERS & LOSERS: Unbound shares drop as calls off sales process | Alliance |
| 27.06.2023 10:01 | EVG | Evgen Pharma's SFX-01 has positive effects for treating a rare cancer | Alliance |
| 27.06.2023 07:00 | EVG | SFX-01 radiosensitisation effect confirmed in-vivo | Reach |
| 20.06.2023 13:59 | EVG | Notice of AGM & Posting of Annual Report | RNS |
| 19.06.2023 10:05 | EVG | Evgen collaborator receives grant from KWF Dutch Cancer Society | Alliance |
| 19.06.2023 07:00 | EVG | Grant Success for Glioblastoma studies | RNS |
| 07.06.2023 11:41 | EVG | Evgen Pharma confident amid Stalicla deal; CFO Moulson to retire | Alliance |
| 07.06.2023 07:00 | EVG | Final Results | RNS |
| 31.05.2023 15:46 | RESI, RFX, EVG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 26.05.2023 11:00 | EVG | Notice of Results | RNS |
| 22.03.2023 11:10 | EVG | IN BRIEF: Evgen Pharma shares up as pharmacokinetic data announced | Alliance |
| 22.03.2023 10:30 | MPAC, ANP, EVG | AIM WINNERS & LOSERS: Pathfinder finds way forward in Mozambique | Alliance |
| 22.03.2023 07:00 | EVG | Preliminary results from Phase 1b study | RNS |
| 16.03.2023 16:35 | EVG | Evgen notes evidence of radiosensitisation by SFX-01 in cancer cells | Alliance |
| 16.03.2023 14:00 | EVG | Price Monitoring Extension | RNS |
| 16.03.2023 11:05 | EVG | Second Price Monitoring Extn | RNS |
| 16.03.2023 11:00 | EVG | Price Monitoring Extension | RNS |
| 16.03.2023 07:00 | EVG | Further evidence of radiosensitisation by SFX-01 | Reach |
| 13.03.2023 12:18 | VRCI, CSFS, SCLP | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
| 13.03.2023 07:00 | EVG | No exposure to Silicon Valley Bank | RNS |
| 25.01.2023 10:40 | EVG | Evgen Pharma completes dosing of clinical trial for SFX-01 tablet | Alliance |
| 25.01.2023 07:00 | EVG | Clinical trial update | RNS |
| 14.12.2022 17:08 | EVG | Grant of Options - Director/PDMR Shareholding | RNS |
| 12.12.2022 11:53 | EVG | EQS-News: Evgen Pharma 'cash runway in pretty good shape' | EQS |
| 08.12.2022 13:57 | EVG | Evgen Pharma loss, operating expenses widen; SFX-01 study on schedule | Alliance |
| 08.12.2022 07:00 | EVG | Half-year Report | RNS |
| 02.12.2022 07:00 | EVG | Notice of Half Year Results | RNS |
| 30.11.2022 14:06 | EVG | Second Price Monitoring Extn | RNS |
| 30.11.2022 14:00 | EVG | Price Monitoring Extension | RNS |
| 16.11.2022 16:11 | EVG | Evgen Pharma starts clinical trial of new SFX-01 tablet | Alliance |
| 16.11.2022 07:00 | EVG | Study started of new SFX-01 tablet formulation | RNS |
| 21.10.2022 11:05 | EVG | Second Price Monitoring Extn | RNS |
| 21.10.2022 11:00 | EVG | Price Monitoring Extension | RNS |
| 13.10.2022 17:55 | COPL, PCA, CRU | CORRECT: Coral Products buys Ecodeck; Evgen Pharma recruits | Alliance |
| 12.10.2022 21:46 | COPL, PCA, CRU | TRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruits | Alliance |
| 12.10.2022 16:41 | EVG | Second Price Monitoring Extn | RNS |
| 12.10.2022 16:35 | EVG | Price Monitoring Extension | RNS |
